Objective: To determine the prevalence of hypertension (HPT) in the acute phase after ischemic stroke (IS) and explore its relationship to outcome.
months after stroke regarding both death and disability. Our study hypothesis is that acute HPT poststroke is associated with worse outcome in the pediatric population. The secondary objectives were to explore the relationship of HPT with age, sex, and stroke subtype.
METHODS A retrospective health records review of all children aged 1 month to 18 years with first IS admitted to the Royal Children's Hospital (RCH) Melbourne between 2003 and 2008 was undertaken. RCH is the tertiary referral center for the city of Melbourne and state of Victoria (population 4.9 million). Data were collected between August 2009 and April 2010. IS was defined as acute-onset neurologic deficit due to obstruction of cerebral circulation confirmed by radiologic imaging. Both arterial and venous ischemic infarctions were included. Cases were identified using a locally held stroke registry, and additional cases were searched using ICD-10 codes. 19 Study inclusion criteria required first acute IS diagnosis, confirmed on neuroimaging. All patients were required to be aged between 1 month and 18 years at the time of diagnosis and to have arrived at the RCH within 48 hours of diagnosis. Exclusion criteria can be found in table 1 but included children with primary hemorrhagic stroke and neonatal and presumed perinatal IS.
Data extracted from health records included demographic data (e.g., age, sex), dates of admission, diagnosis, and discharge. The location of infarct was obtained from the diagnostic imaging and classified according to vascular territory affected (for arterial IS), unilateral or bilateral distribution, and whether cortical and/or subcortical structures were affected in concordance with other studies. 3, 4 Arterial stroke subtype was further classified using the Pediatric Stroke Classification, a pediatric modification of the TOAST (Trial of Org 10172 in Acute Stroke Therapy) system. 20 Consensus for IS diagnosis and classifications were obtained through rating by 2 investigators (L.B., A.G.). Data were collected by a single individual (L.B.) using a standardized data collection form developed specifically for this study.
Acute presentation details recorded included time and location at symptom onset, presenting symptoms, method of arrival to hospital, and underlying conditions and comorbidities. Risk factors were classified consistent with the pediatric stroke literature [21] [22] [23] [24] [25] (table 2) . All BP readings for the first 72 hours after radiologic confirmation of stroke diagnosis were recorded, along with medications including antithrombotics, anticonvulsants, antihypertensives, analgesics, and corticosteroids, and fluids given or medical interventions within this time period. BP values were taken as recorded in the patient records within 72 hours after diagnosis; the method of assessment was usually unknown. HPT was defined as 2 consecutive systolic BP readings $95th percentile for age and height in accordance with the hospital guidelines and the literature. 26 Outcome for death and recurrence, as documented in health records, was determined at 12 months after stroke diagnosis, whereas outcome for neurologic disability and seizures was classified using the closest assessment to the 12-month time point available. A patient was classified as having a neurologic deficit if there were any abnormal findings on neurologic examination by a medical practitioner and/or if neurologic disabilities were documented in the report of allied health professionals. Evaluation of patient records allowed clinical examination findings to be classified using standardized pediatric measures, i.e., Manual Ability Classification System (MACS), 27 Gross Motor Function Classification System (GMFCS), 28 and King's Outcome Scale for Childhood Head Injury (KOSCHI). 29 Retrospective rating of the KOSCHI has been previously described. 29, 30 Recovery levels were as defined by the KOSCHI on a scale of 1 (death) to 5 (good recovery).
Data were analyzed using the STATA statistical package (version 11; StataCorp, College Station, TX). Analysis was undertaken using, as appropriate, parametric and nonparametric statistics. Missing data were excluded from the analysis. The p values were set at 0.05. Pearson x 2 test was applied when sample size was sufficient, and Fisher exact test when sample numbers were ,40, when exploring the relationship between binomial and categorical variables. The Wilcoxon signed rank test was used for nonsymmetrical continuous data to examine change in HPT scores over the 3 days after diagnosis. The relationship between death in the first 12 months and presence of HPT on each of the first 3 days after diagnosis was investigated using Pearson correlation coefficient. Relative risk and 95% confidence intervals (CIs) were also calculated as a univariate analysis using Pearson x 2 test to examine the relationship between HPT and adverse outcome.
Standard protocol approvals, registrations, and patient consents. Audit approval was granted by the Human Research Ethics Committee of RCH Melbourne.
RESULTS
Population and stroke characteristics. One hundred thirty-five patients were identified and radiologic reports were reviewed. One hundred thirtytwo patient records were retrieved. Three records were missing or could not be retrieved and 42 were excluded after detailed review because they did not meet inclusion criteria (table 1) . Most of these cases were excluded because of age at presentation or non-IS diagnosis. Only 9 of the 42 children were excluded on the basis of Table 1 Exclusion criteria for patients presenting to the Royal Children's Hospital Melbourne with acute ischemic stroke
Exclusion criteria

No. excluded
Patient had established infarct on neuroimaging but no acute or subacute event 2
Patient transferred from another hospital >48 h after stroke diagnosis (no information on acute management available)
9
Primary hemorrhagic stroke 5
Neonatal stroke (age younger than 1 mo at time of diagnosis) 11
Presumed perinatal stroke 6
Stroke diagnosis not confirmed by neuroimaging 6
Hypoxic ischemic encephalopathy not conforming to vascular territories 2
Cerebral sinovenous thrombosis without parenchymal damage 1 limited acute data. Therefore, the final study population comprised 90 individuals (table 2) . Patients were aged between 1 month and 16.8 years at diagnosis (median 3.8 years, interquartile range 1.4-9.9 years); more than half of the population was younger than 5 years. There were similar proportions of boys (54%) and girls (46%). Median time to diagnosis was 2 days (interquartile range 1-5 days). Eighty-two patients presented with arterial IS, 7 presented with sinovenous thrombosis, and 1 patient had a combination of both. Arterial infarcts usually involved the middle cerebral artery territory. The most common determined classification was cardioembolic, followed by cerebral arteriopathies. Most patients (75.5%) had multiple risk factors. Classification could not be determined for almost one-third of patients. Twenty-eight children (31.1%) were inpatients of the RCH at the time of diagnosis; of those patients, 70.4% had a known cardiac condition before the event. Only 1 patient had a preexisting diagnosis of systemic HPT; 1 patient had HPT after pleural effusions, and 1 patient had a hypertensive arrest.
BP within 72 hours of diagnosis. Eighty-four patients (93.3%) had $2 BP readings during the 72 hours after diagnosis, enabling hypertensive status to be calculated. Of these, 53 (63.1%) were found to have at least 1 episode of HPT (standard error: 0.053, 95% CI 5 51.9%-73.4%). Nineteen patients (22.6%) experienced an episode of HPT on all 3 days. Eighteen of 53 patients (20%) received antihypertensive medications during the first 72 hours after diagnosis, 12 of whom had 2 recorded readings of HPT. There was no statistically significant association between HPT and any of the risk factors or underlying conditions (table 3) . HPT was more prevalent at both ends of the age spectrum (table 4) .
Outcome at 12 months. Outcome data for death and recurrence were available for 87 of 90 patients (96.7%). Of the 3 patients without follow-up data, 1 was from interstate, 1 moved overseas, and 1 did not have any stroke follow-up for reasons unknown. These 3 patients were excluded from the analysis. Additionally, 1 patient had only 6 months of follow-up available, thus was excluded from the analysis of 12-month mortality and recurrence. Ten children (11.6%) died within the first 12 months, including 7 patients who died during initial hospital admission ranging from 0 to 128 days after stroke diagnosis. In 3 patients, death occurred after discharge at 81, 188, and 336 days postevent. Cause of death was determined to be directly related to the stroke in 7 children.
Sixteen of 86 children (18.4%) experienced recurrent stroke. The median duration of follow-up on neurologic outcome was 336 days (range 0-601 days). KOSCHI ratings were obtained for 86 patients. In the majority, outcome was classified as either "good recovery" (32 patients [37.2%]) or "moderate disability" (42 patients [48.9%]). Ten patients (11.6%) had "poor outcome." MACS scores were obtained for 76 patients and GMFCS scores for 77 patients. Most scored level 1 (61.8%) or 2 (29.0%) on the MACS or the GMFCS scales (79.2% at level 1, 16.9% level 2), meaning that the majority of patients handled objects easily and walked without limitations. Thirty-five patients (38.9%) had a comorbidity or developmental disability before stroke that may have affected their outcome ratings.
Relationship between BP and 12-month outcome. The relative risk of 12-month mortality was 4.5 times higher if the patient experienced HPT (p 5 0.096, 95% CI 5 0.6-34.5). Six of the 7 children who died during admission had BP readings, and in all cases HPT was detected (risk ratio 5 1.7, p 5 0.05, 95% CI 5 1.4-2.0). Six children had radiologic evidence of supratentorial mass effect, 3 had effacement of the basal cisterns but only 2 had evidence of transtentorial herniation, and 1 had tonsillar herniation across the foramen magnum. Relative risk of death was not shown to be significantly different between patients who experienced an episode of HPT on days 1, 2, or 3 postdiagnosis (risk ratio 5 1.8, 1.7, 1.9; p 5 0.3, 0.3, and 0.3, respectively). Number of days hypertensive was shown to correlate with 12-month mortality (Fisher exact test 5 0.098), and more significantly with death during admission (Fisher exact test 5 0.04).
There was no statistically significant relationship between HPT and recurrent stroke (risk ratio 5 1.25, 95% CI 5 0.48-3.25, p 5 0.64) or neurologic deficit (risk ratio 5 1.06, 95% CI 5 0 0.83-1.34, p 5 0.66) (table 5). There was no correlation between HPT and MACS, GMFCS, or KOSCHI rating (p 5 0.2, 0.3, and 0.07, respectively). DISCUSSION In our consecutive sample of children with first IS in childhood, HPT was found in a significant proportion of patients (95% CI 5 52%-73%). Our findings are consistent with a previous retrospective study from the UK that found that 50% of their patients had systolic HPT. 14 Although HPT may not be pathologically significant in all cases, 8 one-third of hypertensive children in our cohort received antihypertensive agents, suggesting it was of clinical significance in at least a proportion of patients. 8 More than half of these children had congenital heart disease, suggesting they are a high-risk population.
Our data suggest that HPT is associated with increased risk of death during admission. The number of days patients experienced HPT correlated with death during admission (p 5 0.043). This association could be a direct consequence of damage induced by prolonged HPT, or it may indicate that HPT is a marker of more severe brain injury. One explanation is that Cushing reflex (HPT and bradycardia) was the cause for the observed HPT as a sign of impending brain herniation. If HPT was shown to be independently linked to both increased intracranial pressure and increased risk of death, then there is the possibility of using high systolic BP to screen for those children in greater need of neurosurgical intervention for increased intracranial pressure.
In adults, HPT has long been known to be a risk factor for stroke because of its relationship with the development of atheromatous deposits and vessel narrowing from intimal hyperplasia, which together predispose to clot formation. 31 HPT cannot actually rupture the small vessels in the brain, but high velocities can cause damage to the vascular wall. 32 Risk of first stroke in adults increases linearly in relation to an individual's usual BP, with every 10 mm Hg increase in diastolic BP inferring an increase in stroke risk of more than one-half. 31, 33 This study was not designed to address the role of preexisting HPT in the etiology of childhood stroke. Acute increases in BP can cause cerebral arterial spasm, which if prolonged can induce ischemia 31, 34 and could have a role in the transient arterial vasculopathy often seen in childhood stroke, and further vessel damage in children with underlying arteriopathies such as moyamoya. However, prospective studies will be required to address this question. Our study focused on the presence of HPT in the acute phase after stroke as a predictor of stroke outcome in children. Regardless of whether the impact of HPT on outcome is a direct or indirect phenomenon, which is difficult to differentiate in a retrospective study, we postulate that HPT could be used as a predictor of poor prognosis. In support of this view, prolonged HPT after traumatic brain injury in childhood has been shown to increase risk of poor outcome. [15] [16] [17] High BP in adults is defined by the World Health Organization as a BP .140/90 mm Hg. Because of developmental differences in children, HPT is classified in relation to age and height. BP is found to increase with both age and body size, 35 thus HPT is defined using population estimates as either systolic or diastolic BP that is $95th percentile for sex, age, and height percentile upon repeated measurement. 26 This definition of HPT, developed by the National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, forms the basis of the RCH guidelines. It is important to recognize, however, that the 95th percentile is for the most part an arbitrary cutoff; patients are asymptomatic, and whether secondary causes exist at this level has not been validated, 36 nor whether BP above this level increases the risk of developing secondary cardiovascular disease.
The American Stroke Association Guidelines on Management of Stroke in Infants and Children advocate control of systemic HPT, 37 but more specific recommendations regarding the use of antihypertensive medication are not provided. Lowering of BP in hypertensive adult patients after stroke has not been shown to have a statistically significant effect on patient outcome 38 and therefore this remains an area of controversy because of concerns that lowering BP in the setting of altered autoregulation may actually worsen cerebral perfusion. 39 This study has limitations because of the retrospective nature of the analysis. This did not allow us to determine the method of BP measurement. Because ambulatory BP monitoring was not performed, it was not possible to determine whether the elevated readings were sustained during the first 72 hours or whether they were attributable to "white coat" HPT. Height data were collected on one-third of children, which did not allow calculation of body mass index. Therefore, we were unable to calculate BP recording adjusted for body mass index and to explore the relationship with outcome. There was no uniform approach to HPT management, which may have had some impact on patient outcome. Similarly, BP recordings were not documented after discharge to determine whether it was a persistent problem and whether such patients may have had undiagnosed preexisting chronic HPT. We did not record any medications the patient was taking long term or as an inpatient before the stroke diagnosis, so it is not known whether the 18 patients who were given antihypertensive medications during the acute period after stroke were receiving long-term antihypertensive treatment; 12 of these patients had either underlying cardiac or vascular conditions, which could be an indication for such treatment. ICD-9 codes are known to have limitations in both sensitivity and specificity. 40 The use of a local stroke registry in addition to the ICD-10 codes improved methodologic rigor, but it is possible that some cases were missed. Given the well-recognized prevalence of delayed diagnosis of pediatric stroke, we acknowledge that we may not have data measuring BP from symptom onset in all cases and that this may influence the results and limit the strength of our conclusions.
We did not find a significant association between HPT and presence of neurologic deficits at 12 months; however, data were limited to what was described in the patients' medical records, which may have underrepresented the degree of disability or impairment. Because neurologic deficits were collapsed into present/absent, mild deficits were grouped equivalently with severe deficits, which may have decreased the strength of associations that could be drawn from this study.
HPT is prevalent in the acute setting after IS diagnosis in children and it is associated with increased risk of death. This suggests there should be careful attention to detection of HPT and consideration should be given to ambulatory BP monitoring in the acute phase and after discharge.
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